Akciğer adenokarsinom tanısı almış hastaların EGFR mutasyon durumu, ALK rearanjmanı, PET-CT suvmax değerleri arasındaki ilişkinin tanımlanması / Definition of the relationship between egfr mutation status, alk rearrangement, PET-CT suvmax values of patients with lung adenocarcinoma.


Arş. Gör. Dr. MERVE HÖRMET İĞDE

Tez Türü: Tıpta Uzmanlık

Tezin Yürütüldüğü Kurum: İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye

Tez Danışmanı: Danışman: Doç. Dr. Özlem Oruç ; Uzman Akın Öztürk

Tezin Onay Tarihi: 2020

Tezin Dili: Türkçe

Özet:

Introduction: We aimed to define the correlation between the EGFR mutation status, ALK rearrangement and PET-CT SUVmax values of patients diagnosed with lung adenocarcinoma. Materıals and Methods: In our study, 732 patients who applied to the oncology polyclinic of Saglik Bilimleri University Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital between January 2014 – December 2019, were histopathologically diagnosed with adenocarcinoma via invasive and non-invasive methods and had had PET-CT before biopsy, were included. The study was planned as a retrospective cohort study and patient data were acquired via patient files and hospital records. Patients were evaluated in terms of their age, sex, smoking status (those having less than 100 cigarettes throughout their lives were accepted as non-smokers and those who had quitted smoking one year before, exsmokers), stage of disease (classified according to the 8.TNM), comorbidities, tumor localizations, EGFR mutation status, ALK rearrangement status and SUVmax values of the primary tumor and lymph nodes in the PET-CT. Results: 732 patients diagnosed with lung adenocarcinoma and meeting exlusion and inclusion criteria, were included in the study. Age average of the patients was 63 years and 76% of them were male and 24% female. Almost half of our patients were actively smoking and 42% of them had cancer history in family. The EGFR mutation frequency was found to be 10.4%. It was determined that there was no correlation between SUVmax measurements and EGFR positiveness. It was found that exon mutations were not significantly correlated with primary and lymph node SUVmax values. Smoking and female sex were effective independent risk factors for EGFR mutation. EGFR mutation was more common among non-smokers and females. It was determined that there was no difference between those with EGFR positive and negative, in terms of mortality. ALK mutation was found to be in the frequency of 3.6%. It was determined that ALK mutation was inversely proportional with age. Age of patients with ALK positive was lower than those with ALK negative. It was determined that there was no significant correlation between ALK positiveness and survival. It was determined that there was no significant correlation between ALK mutation and SUVmax values. Conclusion: Examining our study results; it was determined that EGFR mutation status was not significantly correlated with ALK rearrangement and PET-CT SUVmax. However, fact that our study is monocentered and has a larger range of cases, it is believed to be useful for the correlation of lung adenocarcinoma with molecular biology and clinic factors and to guide future studies.